Clomipramine hydrochloride
SIGMA/C7291 - ≥98% (HPLC), powder
Synonym: 3-
CAS Number: 17321-77-6
Empirical Formula (Hill Notation): C19H23ClN2 · HCl
Molecular Weight: 351.31
EC Number: 241-344-3
MDL Number: MFCD00069234
Linear Formula: C19H23ClN2 · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C19H23ClN2.ClH/c1-21(2 |
| InChI key | WIMWMKZEIBHDTH-UHFFFAOYSA |
| originator | Novartis |
| Quality Level | 200 ![]() |
| SMILES string | Cl.CN(C)CCCN1c2ccccc2CCc3 |
| solubility | 0.1 M HCl: soluble |
| H2O: 25 mg/mL |
| Application: | Clomipramine hydrochloride has been used to manipulate serotonin (5-HT) mechanisms. It has also been used to study its role on bone mass. |
| Application: | Clomipramine hydrochloride has been used: • to study its effect on human serum albumin using UV-visible, fluorescence and circular dichroism (CD) techniques • to block itchy E3 ubiquitin protein ligase (ITCH) ubiquitin transthiolation • as a serotonin reuptake inhibitor • as a homologous to E6AP C terminus (HECT) E3 ligase inhibitor |
| Biochem/physiol Actions: | Clomipramine hydrochloride (CLP) is a amphiphilic drug, with two benzene rings in its structure. It exhibits anti-depressant property by restoring the equilibrium of certain natural materials in the human being. CLP acts as a potential therapeutic for obsessive compulsive disorder. |
| Biochem/physiol Actions: | Tricyclic antidepressant; inhibits serotonin and norepinephrine transporters. |
| Features and Benefits: | This compound is featured on the Biogenic Amine Transporters page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Novartis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | Clomipramine hydrochloride is an antiobsessional drug. It has anticholinergic activity in vitro and in vivo. Clomipramine is used to treat obsessive compulsive disorder and panic disorder. |
| Packaging: | 1, 5 g in poly bottle |
| Symbol | ![]() ![]() GHS07,GHS08,GHS09 |
| Signal word | Danger |
| Hazard statements | H302 - H336 - H370 - H410 |
| Precautionary statements | P260 - P264 - P270 - P273 - P301 + P312 - P308 + P311 |
| Hazard Codes | Xn,N |
| Risk Statements | 63-22-50/53 |
| Safety Statements | 13-20/21-22-24/25-26-28-36/37/39-38-62 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Purity | ≥98% (HPLC) |
| UNSPSC | 12352116 |




